United Therapeutics UTHR Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 354.5%-1.4pp | 355.9%-2.9pp | 358.8%-12.9pp | 371.6%+1.0pp | |
| Operating margin | 188.6%-4.3pp | 192.9%-8.8pp | 201.6%-2.4pp | 204%+91.8pp | |
| Net margin | 163.4%-1.4pp | 164.8%+3.6pp | 161.2%+11.4pp | 149.7%+37.0pp | |
| EBITDA margin | 199.1%-3.3pp | 202.3%-9.1pp | 211.4%-3.6pp | 215%+90.4pp | |
| Free cash flow margin | 141.1%+7.2pp | 133.8%-1.3pp | 135.1%-10.1pp | 145.3%+14.2pp | |
| Returns | |||||
| Return on equity | 79%+1.6pp | 77.4%+8.0pp | 69.4%+2.0pp | 67.4%+14.8pp | |
| Return on assets | 69.1%+4.6pp | 64.5%+8.8pp | 55.7%+3.7pp | 51.9%+12.7pp | |
| Efficiency | |||||
| Asset turnover | 1.7×+0.1× | 1.6×+0.2× | 1.4×0.0× | 1.4×0.0× | |
| Inventory turnover | 9×-0.7× | 9.7×+0.7× | 9×+3.4× | 5.6×+0.4× | |
| Liquidity | |||||
| Current ratio | 25.7×+7.8× | 18×-9.6× | 27.6×-8.9× | 36.5×+7.3× | |
| Quick ratio | 24.5×+7.3× | 17.3×-9.4× | 26.7×-8.6× | 35.3×+7.3× | |
| Cash ratio | 10.9×+3.7× | 7.2×-2.3× | 9.5×-1.6× | 11×-0.5× | |
| Leverage | |||||
| Interest coverage | 223.4×+122× | 101.7×+17.0× | 84.7×-77.4× | 162.1×+66.5× | |
| Per Share | |||||
| Book value per share | $576.06+18.5% | $486.27+8.6% | $447.95+21.1% | $369.91+17.3% | |
| Valuation | |||||
| Market capitalization | $66.86B+16.4% | $57.43B+37.4% | $41.79B+2.0% | $40.98B+21.7% | |
| Price / earnings | 52.6×+0.8× | 51.8×+3.2× | 48.6×-11.0× | 59.6×-14.6× | |
| Price / sales | 21.5×+0.2× | 21.3×+1.8× | 19.5×-2.8× | 22.2×+1.3× | |
| Price / book | 9.7×0.0× | 9.7×+2.2× | 7.5×-1.6× | 9.1×+0.1× | |
| Free cash flow yield | 27.2%+1.9pp | 25.3%-2.5pp | 27.8%+1.0pp | 26.8%+1.5pp | |
| Earnings yield | 31.3%-0.1pp | 31.4%-1.9pp | 33.4%+5.8pp | 27.6%+5.9pp | |
| PEG ratio | 3.8×+1.7× | 2.1×-1.4× | 3.5×+2.2× | 1.3×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are United Therapeutics's profit margins?
- United Therapeutics (UTHR) runs a 86.6% gross margin and a 45.3% operating margin, with a 40.6% net margin.
- Where do United Therapeutics's ratios come from?
- Every ratio is computed from United Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
